Order Article Reprints

Wang Z, Mi T, Bradley HL, Metts J, Sabnis H, Zhu W, Arbiser J, Bunting KD. Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia. Antioxidants. 2021; 10(6):956. https://doi.org/10.3390/antiox10060956

Wang, Zhengqi, Tian Mi, Heath L. Bradley, Jonathan Metts, Himalee Sabnis, Wandi Zhu, Jack Arbiser, and Kevin D. Bunting. 2021. "Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia" Antioxidants 10, no. 6: 956. https://doi.org/10.3390/antiox10060956

Wang, Z., Mi, T., Bradley, H. L., Metts, J., Sabnis, H., Zhu, W., Arbiser, J., & Bunting, K. D. (2021). Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia. Antioxidants, 10(6), 956. https://doi.org/10.3390/antiox10060956